Indegene Ltd Analyst Rating
based on 5 analysts
40.00%
Buy
40.00%
Hold
20.00%
Sell
Based on 5 analysts offering long term price targets for Indegene Ltd. An average target of ₹684
Source: S&P Global Market Intelligence
Indegene Ltd Share analysis
Indegene Ltd price forecast by 5 analysts
Upside of5.00%
High
₹800
Target
₹684.00
Low
₹580
Indegene Ltd target price ₹684, a slight upside of 5% compared to current price of ₹651.45. According to 5 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Indegene Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Indegene Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Indegene Ltd Performance
Day's Low
Day's High
₹626.55Day's Price Range₹657.552 Week's Low
52 Week's High
₹470.152-Week Price Range₹736.3
| Returns % | |
| 1 Month Return | + 8.21 % |
| 3 Month Return | -6.93 % |
| 1 Year Return | + 14.11 % |
| Market Stats | |
| Previous Close | ₹640.15 |
| Open | ₹644.45 |
| Volume | 4.71L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹15,316.80Cr |
Indegene Ltd Key Statistics
| P/E Ratio | 39.84 |
| PEG Ratio | 10.49 |
| Market Cap | ₹15,316.80 Cr |
| P/B Ratio | 0 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 15.77 |
Indegene Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹15,316.80 Cr | 2.82% | 0.54 | ₹336 Cr | ₹2,589 Cr | |
| BUY | ₹1,451.47 Cr | -2.08% | 0.59 | ₹41 Cr | ₹337 Cr | |
| NA | ₹281.01 Cr | -0.24% | 0.50 | NA | NA | |
| NA | ₹192.44 Cr | -1.51% | 0.71 | ₹4 Cr | ₹84 Cr | |
| NA | ₹36.80 Cr | 0.28% | 0.64 | NA | NA |
About Indegene Ltd
Share Price: ₹651.45 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹15,316.80Cr as of today
Revenue: ₹686.80Cr as on September 2024 (Q3 24)
Net Profit: ₹91.70Cr as on September 2024 (Q3 24)
Listing date: 13 May, 2024
| Organisation | Indegene Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Indegene Ltd
Indegene Partners with CliniOps to Enhance Clinical Trials - 10 Jan, 2025
Indegene has formed a strategic partnership with CliniOps to improve clinical trial processes and patient outcomes. The collaboration aims to leverage advanced digital solutions and Indegene's expertise in patient recruitment. Additionally, Indegene reported a 22.3% increase in net profit for Q2 FY25, reflecting strong operational performance.
Insights on Indegene Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, INDGN stock has moved up by 3.3%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 3.79% to 4.82% in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 92.37% to 92.01% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 2.31% to 1.64% in Sep 2024 quarter
Indegene Ltd Financials
Index Inclusions
Indegene Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 0% | 0.00 | |
| Foreign Institutions | 4.82% | 27.09 | |
| Mutual Funds | 1.64% | ||
| Retail Investors | 92.01% | ||
| Others | 1.53% |
Indegene Ltd Key Indicators
Indegene Ltd Valuation
Indegene Ltd in the last 5 years
Lowest (32.56x)
June 4, 2024
Today (39.84x)
January 17, 2025
Industry (97.73x)
January 17, 2025
Highest (44.81x)
October 1, 2024
Indegene Ltd Earnings and Dividends
Indegene Ltd Earnings Results
Indegene Ltd’s net profit jumped 22.27% since last year same period to ₹91.70Cr in the Q2 2024-2025. On a quarterly growth basis, Indegene Ltd has generated 4.56% jump in its net profits since last 3-months.
Read More about Earnings Results
Indegene Ltd Technicals Summary
Bearish
Neutral
Bullish
Indegene Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Indegene Ltd
Indegene Ltd share price today stands at ₹651.45, Open. ₹644.45 ; Previous Close. ₹640.15 ; High. ₹657.5 ; Low. ₹626.55 ; 52 Week High. ₹736.3 ; 52 Week Low: ₹470.1.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Indegene Ltd shares.
Indegene Ltd is listed on NSE
Indegene Ltd is listed on BSE
- Today’s highest price of Indegene Ltd is ₹657.5.
- Today’s lowest price of Indegene Ltd is ₹626.55.
PE Ratio of Indegene Ltd is 39.84
PE ratio = Indegene Ltd Market price per share / Indegene Ltd Earnings per share
Today’s traded volume of Indegene Ltd(INDGN) is 4.71L.
Today’s market capitalisation of Indegene Ltd(INDGN) is ₹15316.8Cr.
| Indegene Ltd(INDGN | Price |
|---|---|
52 Week High | ₹736.3 |
52 Week Low | ₹470.1 |
Indegene Ltd(INDGN) share price is ₹651.45. It is down -11.52% from its 52 Week High price of ₹736.3
Indegene Ltd(INDGN) share price is ₹651.45. It is up 38.58% from its 52 Week Low price of ₹470.1
| Indegene Ltd(INDGN | Returns |
|---|---|
1 Day Returns | 11.3% |
1 Month Returns | 8.21% |
3 Month Returns | -6.93% |
1 Year Returns | 14.11% |